Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 4
2004 9
2005 3
2006 6
2007 6
2008 5
2009 10
2010 7
2011 11
2012 9
2013 6
2014 11
2015 13
2016 17
2017 12
2018 13
2019 21
2020 23
2021 27
2022 32
2023 29
2024 16

Text availability

Article attribute

Article type

Publication date

Search Results

254 results

Results by year

Filters applied: . Clear all
Page 1
Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury.
STARRT-AKI Investigators; Canadian Critical Care Trials Group; Australian and New Zealand Intensive Care Society Clinical Trials Group; United Kingdom Critical Care Research Group; Canadian Nephrology Trials Network; Irish Critical Care Trials Group; Bagshaw SM, Wald R, Adhikari NKJ, Bellomo R, da Costa BR, Dreyfuss D, Du B, Gallagher MP, Gaudry S, Hoste EA, Lamontagne F, Joannidis M, Landoni G, Liu KD, McAuley DF, McGuinness SP, Neyra JA, Nichol AD, Ostermann M, Palevsky PM, Pettilä V, Quenot JP, Qiu H, Rochwerg B, Schneider AG, Smith OM, Thomé F, Thorpe KE, Vaara S, Weir M, Wang AY, Young P, Zarbock A. STARRT-AKI Investigators, et al. N Engl J Med. 2020 Jul 16;383(3):240-251. doi: 10.1056/NEJMoa2000741. N Engl J Med. 2020. PMID: 32668114 Free article. Clinical Trial.
Edaravone Dexborneol Versus Edaravone Alone for the Treatment of Acute Ischemic Stroke: A Phase III, Randomized, Double-Blind, Comparative Trial.
Xu J, Wang A, Meng X, Yalkun G, Xu A, Gao Z, Chen H, Ji Y, Xu J, Geng D, Zhu R, Liu B, Dong A, Mu H, Lu Z, Li S, Zheng H, Chen X, Wang Y, Zhao X, Wang Y; TASTE Trial Investigators†. Xu J, et al. Stroke. 2021 Mar;52(3):772-780. doi: 10.1161/STROKEAHA.120.031197. Epub 2021 Feb 16. Stroke. 2021. PMID: 33588596 Clinical Trial.
Initiation of continuous renal replacement therapy versus intermittent hemodialysis in critically ill patients with severe acute kidney injury: a secondary analysis of STARRT-AKI trial.
Wald R, Gaudry S, da Costa BR, Adhikari NKJ, Bellomo R, Du B, Gallagher MP, Hoste EA, Lamontagne F, Joannidis M, Liu KD, McAuley DF, McGuinness SP, Nichol AD, Ostermann M, Palevsky PM, Qiu H, Pettilä V, Schneider AG, Smith OM, Vaara ST, Weir M, Dreyfuss D, Bagshaw SM; STARRT-AKI Investigators. Wald R, et al. Intensive Care Med. 2023 Nov;49(11):1305-1316. doi: 10.1007/s00134-023-07211-8. Epub 2023 Oct 10. Intensive Care Med. 2023. PMID: 37815560 Clinical Trial.
2-(4-Methyl-phen-yl)-1H-imidazo[4,5-f][1,10]phenanthroline.
Ma L, Lu L, Zhu M. Ma L, et al. Among authors: lu l. Acta Crystallogr Sect E Struct Rep Online. 2011 Apr 1;67(Pt 4):o864-5. doi: 10.1107/S1600536811008853. Epub 2011 Mar 12. Acta Crystallogr Sect E Struct Rep Online. 2011. PMID: 21754145 Free PMC article.
An overview and future prospects of sialic acids.
Yang H, Lu L, Chen X. Yang H, et al. Among authors: lu l. Biotechnol Adv. 2021 Jan-Feb;46:107678. doi: 10.1016/j.biotechadv.2020.107678. Epub 2020 Dec 5. Biotechnol Adv. 2021. PMID: 33285252 Review.
Native and engineered extracellular vesicles for wound healing.
Lu S, Lu L, Liu Y, Li Z, Fang Y, Chen Z, Zhou J. Lu S, et al. Among authors: lu l. Front Bioeng Biotechnol. 2022 Dec 9;10:1053217. doi: 10.3389/fbioe.2022.1053217. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 36568307 Free PMC article. Review.
254 results